Digital Pathology Market Size, Share and Global Trend By Technology (Whole Slide Imaging Image Analytics Information, Digital Cytopathology, Digital Holography, Microscopy), By Application (Hematology Analysis, Blood Cell Counting, Urine Sediment Analysis, Disease Diagnosis),By End User (Pathology Laboratories, Hospitals, Pharmaceutical and Biotechnology Companies, Diagnostic Centers), Geography Forecast till 2021-2028

In 2018, Aiforia Technologies Oy (previously known as Fimmic), a Finland based software company developed Aiforia, artificial intelligence, and cloud-based application, with the aim to offer extensive image analysis as well as to improve speed and precision in tissue-based diagnostics. Recently, the U.K. government announced a multi-million-pound joint investment in conjunction with major market players with the aim to digitize all laboratories under the National Health Services (NHS). This strategic move of the U.K. government will help all the radiography laboratories to expand access to advanced digital pathology service.

Digital Pathology is playing a vital role in improving workflow, by connecting pathologists around the world, and performing important functions such as capturing, storage, and sharing the images with healthcare providers around the world, which is responsible for increasing productivity and reducing costs of pathological processes. In 2017, Olympus Corporation entered in a joint research alliance with Chugoku Cancer Centre for development computer-aided diagnosis using artificial intelligence for gastric biopsy specimens. 

To gain extensive insights into the market, Request for Customization

The Digital Pathology Market is expected to witness huge growth owing to increasing government focus to implement advanced systems for better efficiency and quick response. Combined with this, increasing patient pool, delays in radiography diagnostics due to high waiting time are projected to offer a favorable environment for the adoption of digital pathology systems during the forecast period. 

A lack of well-established internet infrastructure, especially in emerging countries, combined with higher installation and maintenance cost of the digital pathology systems is expected to hamper the growth of the digital pathology market, especially in emerging nations, where the patient pool is comparatively higher. 

Key Players Covered 

Some of the major companies that are present in the global digital pathology market are 3DHistech, Inc., ZIH Corp, Mikroscan Technologies, Inc., Objective Pathology Services, Hamamatsu Photonics K.K., F. Hoffmann-La Roche Ltd., Primera Technology, CEREBRUM CORP, Nikon Corporation, Biogenuix, Indica Labs, Inc., Koninklijke Philips N.V., Sectra AB, Inspirata, LigoLAb, Leica Biosystems Nussloch GmbH, Olympus Corporation, and others. 

SEGMENTATION 

Currently, among end-user segments, pathology laboratories are holding the major share of the global digital pathology due to the higher number of installations of digital systems in these laboratories. 

Key Insights 

• Key mergers and acquisitions
• Technological advancements
• Key strategies of leading market players
• Key performance indicators for the global digital pathology market 

Regional Analysis 

North America is expected to hold a major share in the global digital pathology market owing to well-developed healthcare infrastructure, accessibility of expertise and increasing focus on digitization of diagnostic procedures. Moreover, technological advancements by leading market players are expected to increase the adoption of digital pathology systems in the region during the forecast period. Europe region is expected to register considerable CAGR owing to massive government funding and investments for implementation of highly configured systems with the aim to streamline the processes. Asia Pacific region is likely to gain market share in the global digital pathology market from 2018-2025, due to an expected rise in spending on image processing and analytics software products. Further, the trends of machine learning and artificial intelligence in the Asia Pacific region expected to propel the adoption of the global digital pathology market.  

Key Industry Developments

• In September 2018, Spintellx Inc., announced its investment in digital pathology to develop a new software solution tool which will provide spatial analytics for pathologists in drug development and cancer biopharma companies.
• In October 2018, Columbus based digital pathology start-up, Deep Lens raised an estimated US$ 3.2 Mn through seed funding, with aim to strengthen its product portfolio as well as boost the new solutions for digital pathology.
• In October 2018, TRIBVN Healthcare, a strong player in digital pathology market announced the launch of CaloPix 4.0.0., an advanced software solution for digital pathology with extensive configuration to provide image analysis and management.
• In January 2019, Roche launched its new enterprise software for digital pathology, uPath. uPath software offers facility to examine high resolution images along with patient conditions within one view.